Valye reports for unlimited access

Concentra Group Holdings Parent, Inc. is a healthcare company specializing in occupational health centers and onsite health clinics. The company provides services related to workers' compensation, employer services, and consumer health through its network of centers. It maintains active investor communications through quarterly earnings calls and regularly reports financial results in SEC filings. The company has demonstrated revenue growth and profitability in recent quarters, supported by a solid liquidity position as of mid-2026.

Warby Parker Inc. is a public benefit corporation that designs, manufactures, and sells eyewear and provides comprehensive eye care services. The company operates an omnichannel retail model combining digital commerce and physical stores, with 323 locations as of end 2025. It offers glasses starting at $95 including prescription lenses, contact lenses from leading brands, and eye exams both in-store and via telehealth. Warby Parker emphasizes customer experience, innovation, and social impact through its Buy a Pair, Give a Pair program. The company leverages proprietary technology such as Virtual Try-On and Virtual Vision Test to enhance the shopping and vision care experience. Its supply chain is vertically integrated and globally sourced with compliance and quality controls. Growth initiatives focus on expanding brand awareness, retail footprint, AI-powered intelligent eyewear partnerships, and holistic vision care offerings. The U.S. eyewear market is large and growing, with increasing demand driven by rising myopia and digital eye strain. Warby Parker competes with large integrated optical players and online-only retailers, differentiating through brand, quality, price, and innovation [S1].

Arteris, Inc. develops and licenses semiconductor system IP technology focused on Network-on-Chip (NoC) interconnects and SoC integration automation software. Founded in 2003, it is a pioneer and global leader in NoC IP, enabling efficient on-chip communication for complex SoCs and chiplets. Its solutions connect processors, memory, and logic IP blocks to meet design, performance, and power goals across multiple end markets. The company licenses its IP and software under a model combining license fees, support and maintenance fees, and royalties. It has enhanced its offerings through acquisitions and serves customers including semiconductor companies, system-level firms, and OEMs. Arteris’ products are incorporated in billions of production SoCs, addressing growing complexity driven by AI, 5G/6G, automotive electrification, and enterprise computing. The company faces competition from larger IP providers and internal development teams, and operates in a rapidly evolving technological landscape [S1].

Consolidated Edison Inc is a regulated utility company operating primarily through its subsidiaries CECONY and O&R, serving New York City, Westchester County, parts of Queens, Bronx, and northern New Jersey. The company provides electric, gas, and steam services to residential, commercial, and industrial customers. Its transmission segment, Con Edison Transmission, develops and invests in electric transmission projects under Federal Energy Regulatory Commission oversight. The company’s business model relies on regulated rate plans with mechanisms to reconcile uncollectible expenses and late payment charges, which are subject to annual caps limiting customer bill impacts. The company faces challenges related to aged accounts receivable balances, partly due to collection suspensions during the COVID-19 pandemic, which have affected liquidity. Financially, the company reported revenues of approximately $5.1 billion and net income of $924 million for Q1 2026, with a current ratio of 1.19 indicating moderate short-term liquidity. Recent quarterly earnings reports indicate profitability and revenue growth, with market attention on dividend prospects.

Compass Minerals International Inc is a mining company incorporated in Delaware, trading on the NYSE under the ticker CMP. The company focuses on mineral extraction and related operations, with principal offices in Overland Park, Kansas. It maintains liquidity with a current ratio above 2.0 as of June 30, 2026, and reports periodic net losses and earnings per share declines in recent quarters. Leadership changes include a new Chief Operating Officer appointed in August 2026 with extensive mining industry experience.

Gevo, Inc. is a Delaware corporation founded in 2005, operating as a growth-oriented carbon abatement company. Its mission is to provide solutions for greenhouse gas emissions in transportation sectors not suitable for electrification or hydrogen. The company transforms renewable energy and carbon from photosynthesis into energy-dense, drop-in hydrocarbon fuels such as jet fuel, gasoline, and diesel. Gevo's technology includes proprietary Alcohol-to-Jet (ATJ) plant designs and processes, which are modularized for scalable deployment. The company operates a low-carbon ethanol production facility in North Dakota with integrated carbon capture and sequestration, and a renewable natural gas facility in Iowa producing RNG from dairy manure. Revenue is generated from ethanol and related products, RNG, environmental attributes including carbon credits, hydrocarbon products, and licensing and software services. Gevo benefits from federal tax credits and monetizes carbon credits in voluntary and compliance markets. The company reported revenues of $42.9 million for Q1 2026 and a net loss of $176.9 million for Q2 2026, with liquidity ratios indicating a current ratio of 2.7 and cash ratio of 5.99 as of June 30, 2026 [S2].

OneIM Acquisition Corp. is a blank check company incorporated in the Cayman Islands in September 2025. It is formed to pursue a merger, amalgamation, share exchange, asset acquisition, or similar business combination with one or more target businesses. The company completed its IPO in January 2026, issuing units consisting of Class A ordinary shares and warrants, raising gross proceeds of $287.5 million, which are held in a trust account. The company has not commenced operations or generated revenues and focuses on identifying and completing a business combination. It incurs costs related to due diligence, public company compliance, and administrative services provided by its sponsor and affiliates. The company’s management team includes experienced professionals with backgrounds in investment and finance.

AEye Inc develops and commercializes physical AI sensing solutions based on active lidar technology for vehicle autonomy, advanced driver-assistance systems (ADAS), robotic vision, and various non-automotive markets including rail, aerospace, defense, and smart infrastructure. The company’s Intelligent Sensing Platform features a software-definable, solid-state lidar sensor with adaptive scanning and signal processing designed for safety-critical applications. AEye’s modular and software-adaptable platform supports multiple markets and leverages partnerships with Tier 1 and Tier 2 automotive suppliers for manufacturing and integration, as well as collaborations with system integrators and software partners in non-automotive domains through its OPTIS™ platform. The company’s business model depends heavily on maintaining relationships with Tier 1 automotive suppliers to secure design wins and commercial agreements with OEMs. AEye has transitioned from Continental AG to LITEON as its Tier 1 partner and has strategic collaborations including integration with NVIDIA DRIVE AGX. The company has incurred net losses since inception and continues to invest in R&D, manufacturing capacity, and commercialization efforts while managing risks related to supply chain, market adoption, and capital requirements.

Datadog Inc is a technology company providing a cloud-based AI-powered observability and security platform that integrates multiple monitoring and security capabilities into a unified SaaS offering. The platform supports infrastructure monitoring, application performance monitoring, log management, user experience monitoring, cloud security, and service management, among other functions. Revenue is primarily subscription-based, with customers able to purchase additional products and features. The company serves a broad customer base across industries and geographies, with approximately 32,700 customers as of December 31, 2025, and international revenue representing about 29% of total revenue. Datadog faces competition from established technology companies and cloud providers and invests heavily in product development, sales and marketing, and international expansion. The company has reported significant revenue growth and periods of profitability but also faces risks related to customer retention, cybersecurity, and macroeconomic conditions.

Chicago Rivet & Machine Co. manufactures and sells rivets, cold-formed fasteners, screw machine products, and automatic rivet setting machines and related parts. The company operates primarily in two segments: Fastener, which includes rivets and fasteners mainly serving the automotive sector, and Assembly Equipment, which includes automatic rivet setting machines and related tools. Revenue recognition varies by segment, with the fastener segment recognizing revenue upon shipment and the assembly equipment segment recognizing revenue based on progress toward completion of contracts. The company’s customer base is concentrated in the automotive industry, which has experienced production slowdowns affecting sales volumes. The company’s management evaluates segment performance based on gross profit, operating income less depreciation, and capital expenditures. The company has a code of ethics and no equity compensation plans. It has accrued liabilities related to a settlement payable over five years. The company’s financial statements are prepared under the going concern assumption, though there is substantial doubt due to recurring losses and liquidity challenges [S1][S2].

Globus Medical Inc. is a medical device company specializing in musculoskeletal solutions, including implants and enabling technologies. The company markets human tissue products classified as Section 361 HCT/Ps, which are subject to regulatory oversight but not premarket clearance. It relies on a limited number of third-party suppliers for critical components, including human tissue, which introduces supply chain risks. The company faces competitive pressures from physician-owned distributorships and healthcare industry consolidation. Its Enabling Technologies products have long sales cycles and warranty obligations. Globus Medical maintains a geographically dispersed sales network of direct representatives and independent distributors. The company is subject to U.S. healthcare fraud and abuse laws and manages intellectual property risks. As of Q2 2026, it reported revenues of $789.6 million and net income of $151.6 million, with strong liquidity metrics.

South Plains Financial, Inc. is a bank holding company headquartered in Lubbock, Texas, with its wholly-owned subsidiary City Bank, one of the largest independent banks in West Texas. The company operates 24 full-service branches and 7 loan production offices across seven geographic markets in Texas and New Mexico. Its principal business activities include commercial and retail banking, mortgage origination and servicing, trust services, and investment services. The company emphasizes a relationship-based credit culture with disciplined underwriting and active credit risk management. It has a history of growth through acquisitions, including a recent merger agreement with BOH Holdings, Inc. The company is listed on Nasdaq under the ticker SPFI [S1].

Silvaco Group, Inc. develops and licenses semiconductor design and manufacturing software and semiconductor intellectual property. Its TCAD products simulate and optimize semiconductor manufacturing processes, including AI-enhanced digital twin technology. The EDA suite supports integrated circuit design from capture through verification and yield analysis. The SIP portfolio offers silicon-proven IP for interfaces, logic libraries, embedded memory, and automotive applications. The company serves foundries, IDMs, fabless companies, and academia worldwide, with a strong presence in Asia and the Americas. Sales are primarily direct with multi-year license agreements. Silvaco invests heavily in R&D and holds a broad patent portfolio to protect its technology. The semiconductor industry’s cyclical nature and rapid technological change influence Silvaco’s business dynamics.

NETGEAR, INC. is a Delaware-incorporated technology company specializing in consumer networking equipment, notably routers. The company operates in a competitive market with significant regulatory oversight, including recent FCC regulations affecting foreign-made routers. NETGEAR has secured conditional approval under these regulations, enabling ongoing product launches and software updates. The company maintains a comprehensive cybersecurity risk management framework, with oversight by a dedicated board committee and experienced management personnel. Financial disclosures for Q2 2026 show a net loss and revenue decline, with strong liquidity ratios indicating solid short-term financial health. NETGEAR regularly communicates financial results and operational updates through SEC filings and public earnings calls.

Lightbridge Corporation focuses on developing next-generation metallic nuclear fuel for water-cooled reactors, aiming to enhance safety, economic performance, and proliferation resistance. The company’s Lightbridge Fuel™ is designed to operate at lower temperatures with superior heat transfer properties compared to traditional fuel. Lightbridge collaborates with the U.S. Department of Energy and Idaho National Laboratory through strategic agreements to conduct research, development, and testing activities. The company is advancing toward manufacturing readiness, including conceptual design and feasibility studies for a pilot-scale fuel fabrication facility. Lightbridge funds its operations primarily through equity sales and maintains a strong cash position to support ongoing R&D and organizational expansion. The company has no commercial revenue and reports net losses consistent with its development stage.

Trade Desk, Inc. is a global leader in advertising technology, providing a self-service, AI-powered platform that enables advertisers and agencies to create, manage, and optimize digital advertising campaigns across a broad range of formats, channels, and devices. The platform integrates extensive third-party and proprietary data, advanced AI capabilities, and a rich ecosystem of inventory and publisher partners to deliver precise targeting and campaign optimization. The company focuses on the buy side, maintaining independence and objectivity, and generates revenue primarily through platform fees based on client spend and value-added services. Trade Desk supports omnichannel advertising including connected television (CTV), audio, display, native, and digital-out-of-home, and offers extensive customization through APIs. The company maintains a high client retention rate and invests continuously in technology and platform enhancements, including AI and identity solutions. Seasonality affects advertising spend, with the fourth quarter typically the busiest period. Trade Desk reported net income of $64.4 million and EPS of $0.14 for Q2 2026, with a strong liquidity position as of June 30, 2026 [S1][S2].

Onto Innovation Inc. specializes in the design, development, manufacture, and support of metrology and inspection tools for the semiconductor industry. Its product portfolio includes optical critical dimension (OCD) metrology, thin film metrology, wafer inspection, advanced packaging lithography, and process control analytical software. The company serves semiconductor wafer manufacturers, IC fabricators, and advanced packaging manufacturers globally, as well as specialty device markets such as LEDs, MEMS, and power devices. Onto Innovation's solutions support both front-end wafer fabrication and back-end packaging processes, enabling yield enhancement and process control. The company invests significantly in research and development to maintain technological leadership and recently expanded its portfolio through the acquisition of Semilab USA, adding advanced contamination monitoring and materials characterization products. Manufacturing operations are located in multiple U.S. sites and contract manufacturers worldwide. The company faces competition from established players like KLA, Nova, and Camtek across its product segments [S1].

Octave Specialty Group, Inc. is a specialty insurance company operating primarily in two segments: Specialty Property & Casualty Insurance and Insurance Distribution. The Specialty Property & Casualty segment focuses on underwriting diversified commercial and personal liability risks through program administrators. The Insurance Distribution segment grows via organic growth, de-novo businesses, and acquisitions, supported by centralized technology services. The company completed the sale of its legacy financial guarantee business in 2025 and has since acquired ArmadaCorp, expanding its product offerings in supplemental health and benefits. Octave also increased its ownership in key subsidiaries, consolidating operations. The company is regulated by multiple insurance authorities in the U.S., Bermuda, and the UK. Financially, the company reported $82.995 million in revenues and a net loss of $12.156 million for Q2 2026, with increased premiums written and commission income driven by growth initiatives. Octave manages investment portfolios with a focus on liquidity and risk-adjusted returns. The company faces risks from insurance market cycles, catastrophic events, regulatory changes, and operational risks including reputational harm and liquidity constraints.

Investar Holding Corp operates as a bank holding company with its primary banking operations conducted through Investar Bank. The bank is regulated under OCC guidelines and maintains capital ratios that classify it as well-capitalized. The company manages credit risk through a CECL-based allowance for credit losses, incorporating both quantitative data and qualitative adjustments based on economic and portfolio factors. Its loan portfolio is diversified across real estate and commercial loans. The company also engages in interest rate swap contracts to manage interest rate risk and leases real estate to support branch operations.

Cryoport, Inc. specializes in integrated, temperature-controlled supply chain solutions for the life sciences industry, with a particular emphasis on supporting the cell and gene therapy market. The company offers services and products that ensure the safe storage, handling, and delivery of temperature-sensitive biological materials globally. Its operations span the Americas, Europe, the Middle East, Africa, and Asia-Pacific regions. Cryoport's business segments include Life Sciences Services, which covers BioLogistics and BioStorage/BioServices, and Life Sciences Products, which includes cryogenic systems and related accessories. The company supports a broad customer base including biopharmaceutical, pharmaceutical, animal health, reproductive medicine, academic, research, and government sectors. Cryoport has divested its CRYOPDP business and formed a strategic partnership with DHL to enhance its global reach, particularly in EMEA and APAC regions.

SUI Group Holdings Ltd. is a Minnesota-based company listed on Nasdaq under the ticker SUIG. The company’s core business model centers on a digital asset treasury strategy primarily involving SUI tokens. It also selectively allocates capital to loans and minority equity investments in private digital asset, financial technology, and artificial intelligence entities, which are complementary to its broader investment thesis. These investments are typically illiquid and subject to regulatory and operational risks. The company holds its digital assets in custody with BitGo and has entered into loan agreements to support acquisitions in the digital asset ecosystem, including a notable loan to Mustang Funding, LLC, which has experienced financial difficulties. SUI Group’s financial disclosures show a net loss and liquidity constraints as of mid-2026. The company is subject to risks from cybersecurity, regulatory changes, and the evolving landscape of agentic AI.

TFS Financial CORP operates as a financial institution primarily engaged in mortgage lending and home equity loans. Its asset base includes mortgage loans held for investment, home equity loans, and other loan types. The company funds its operations through deposits, certificates of deposit, and borrowed funds, including advances from the Federal Home Loan Bank. It manages interest rate risk through interest rate swaps and maintains allowances for credit losses. The company reported growth in loan originations and net interest income in recent fiscal periods, with a focus on maintaining liquidity and capital adequacy.

SANUWAVE Health, Inc. is a medical technology company focused on wound care and related therapeutic solutions. The company operates in the healthcare sector and is publicly traded on Nasdaq under the ticker SNWV. It has reported recent quarterly revenues and losses, with a focus on commercial growth in wound care markets. The company has undergone financial restatements related to sales and use tax liabilities and maintains liquidity with a current ratio above 1.0 as of mid-2026.

Verrica Pharmaceuticals Inc. develops and commercializes medications for dermatologic diseases, focusing on clinician-administered therapies addressing high unmet needs. Its commercial product, YCANTH (VP-102), is FDA-approved for molluscum contagiosum in patients aged two years and older and launched in the U.S. in August 2023. The company is developing YCANTH for common warts, initiating a global Phase 3 clinical program in 2025. VP-315, an oncolytic peptide injectable, is in development for basal cell carcinoma with Phase 3 planning underway. Verrica collaborates with Torii Pharmaceutical for development and commercialization in Japan, where YCANTH is approved and launched. The company operates a specialized U.S. sales force targeting dermatologists and pediatricians and has secured insurance coverage for YCANTH covering approximately 250 million lives in the U.S. Manufacturing is outsourced, with cantharidin sourced naturally. Financially, Verrica reported Q2 2026 revenue of $5.9 million and a net loss of $13.2 million, with liquidity ratios indicating moderate short-term financial health. The company has a secured credit facility with covenants and milestone-based funding.

SpyGlass Pharma, Inc. focuses on developing sustained drug delivery systems for chronic eye diseases, primarily through its SpyGlass Platform. Its lead candidate, the BIM-IOL System, combines proprietary drug pads with an intraocular lens to deliver bimatoprost over three years during cataract surgery. The company is in late-stage clinical development, conducting Phase 3 trials with enrollment expected to complete in 2027. It has no commercial products or revenues and relies on equity financing to fund operations. SpyGlass Pharma depends on third-party manufacturers and CROs and holds intellectual property licensed from the University of Colorado. The company faces risks related to clinical development, regulatory approval, manufacturing, intellectual property, and market acceptance.

Becton Dickinson & Co (BD) is a global medical technology company that develops, manufactures, and sells a broad range of medical supplies, devices, laboratory equipment, and diagnostic products. BD operates worldwide through five principal segments: Medical Essentials, Connected Care, BioPharma Systems, Interventional, and Life Sciences. The Life Sciences segment includes units focused on specimen management, diagnostic solutions, and biosciences, serving a diverse customer base including hospitals, laboratories, clinics, blood banks, healthcare workers, physicians, academic and government institutions, and pharmaceutical and biotechnology companies. The Interventional segment provides vascular, urology, oncology, and surgical specialty products, including disposable and implantable devices, to hospitals, ambulatory surgery centers, healthcare professionals, extended care facilities, and patients via homecare. BD markets its products globally through independent distribution channels and direct sales. The company’s strategy emphasizes growth through innovation in smart devices, robotics, analytics, and artificial intelligence to improve healthcare outcomes and reduce costs. BD faces regulatory challenges including FDA clearances and compliance with evolving EU medical device regulations, as well as risks related to intellectual property, indebtedness, and ongoing strategic transactions such as the combination of its Biosciences and Diagnostic Solutions business with Waters Corporation.

Alps Group Inc operates through subsidiaries primarily in Malaysia, focusing on biotechnology research, medical services, and wellness solutions. Its business model includes commercial healthcare services such as cellular therapy, medical testing, laboratory, and aesthetic beauty services, often delivered in collaboration with third-party providers who handle marketing and service delivery while Alps provides facilities and operational support. The company has experienced revenue growth over recent years but continues to operate at a net loss. It manages financial risks through established policies and maintains oversight through its board and audit committee. Alps Group also invests in quoted equity instruments and manages related price risks. The company is subject to Nasdaq listing requirements and has received a minimum bid price deficiency notice. It is advancing personalized cancer care initiatives through a patient-derived organoid program.

Ernexa Therapeutics Inc. operates in the biotechnology sector developing synthetic allogeneic induced mesenchymal stem cell (iMSC) therapies. Its lead candidate, ERNA-101, targets ovarian cancer and autoimmune diseases, progressing toward clinical trials with an IND filing nearing completion. The company has demonstrated promising preclinical efficacy and is engaged in strategic programs such as the JETRO Japan Entry Acceleration Program. Financially, Ernexa maintains liquidity with over $4 million in cash and a current ratio above 2, though it reported a net loss in the latest quarter. The company has taken steps to maintain Nasdaq listing compliance, including reverse stock splits and capital raises, but remains subject to ongoing regulatory and market risks.

Pacific Biosciences of California, Inc. develops and manufactures advanced sequencing technologies based on its proprietary Single-Molecule Real-Time (SMRT) sequencing platform. Its HiFi long-read sequencing technology provides highly accurate, long DNA and RNA reads enabling comprehensive analysis of genomes, transcriptomes, and epigenomes. The company’s products support applications in human germline sequencing, rare disease research, oncology, infectious disease surveillance, and plant and animal sciences. PacBio offers sequencing instruments (Revio, Vega, Sequel), consumables (SMRT Cells, reagents), and software solutions. The company markets globally to research institutions, clinical labs, pharmaceutical companies, and agricultural firms. PacBio completed an asset sale of short-read sequencing technology assets to Illumina in January 2026. The company invests heavily in R&D to improve throughput, reduce costs, and expand applications. Manufacturing is conducted primarily in Menlo Park, California, with some sole-sourced components. PacBio faces risks related to commercialization, profitability, manufacturing, customer concentration, competition, intellectual property, and regulatory compliance.

Savers Value Village, Inc. operates as a leading for-profit thrift retailer in North America and Australia, with 375 stores under various banners. The company’s business model involves purchasing secondhand goods donated to non-profit partners, processing and merchandising these items in stores, and selling unsold or unsuitable items to wholesale customers for reuse or repurposing. It emphasizes a hyper-local, socially responsible procurement strategy, sustainability, and a treasure-hunt shopping experience with low average prices. The company leverages technology and data analytics to optimize pricing, labor efficiency, and inventory management. It maintains a large loyalty program and pursues growth through new store openings and operational innovation.

Granite Ridge Resources, Inc. operates as a scaled energy company providing exposure similar to energy private equity through a portfolio of operated partnerships and traditional non-operated assets. The company holds interests in six prolific unconventional basins across the United States, including the Permian, Eagle Ford, Bakken, Haynesville, Denver-Julesburg, and Appalachian basins. Its business model involves managing a diversified portfolio of oil and gas assets, participating in new well developments alongside experienced operators, and sourcing high-return opportunities. Granite Ridge emphasizes maintaining a low leverage profile, prudent balance sheet management, and paying quarterly dividends subject to financial and legal conditions. The company uses proprietary data and technology to evaluate investment opportunities and employs hedging strategies to mitigate commodity price risk. As of mid-2026, Granite Ridge had approximately 250 net producing wells and reported net income and earnings per share for the quarter ended June 30, 2026 [S1][S2].

Optimum Communications, Inc. is a publicly traded company incorporated in Delaware and listed on the New York Stock Exchange under the ticker OPTU. The company operates in the communications sector, though specific industry details are not fully disclosed in the available filings. It has recently reported quarterly financial results showing revenues in the low billions and net losses, with significant current liabilities exceeding current assets as of mid-2026. The company has undertaken financial restructuring and capital raising activities, including private placements and credit facility amendments, to manage liquidity and support operations.

Income Opportunity Realty Investors Inc is a publicly reporting company with available financial data from SEC filings through mid-2026. The company reported net income and earnings per share for the quarter ended June 30, 2026, alongside a significant level of current assets. The company has undergone leadership changes and insider ownership activity recently. Specific sector and industry classifications are not disclosed in the available data.

Dorchester Minerals, L.P. operates as a publicly traded Delaware limited partnership primarily engaged in the acquisition, ownership, and administration of mineral, royalty, overriding royalty, net profits, and leasehold interests in oil and natural gas properties. Its assets span 594 counties and parishes across 28 states. The company receives monthly payments representing 96.97% of net profits from properties owned by its Operating Partnership. It focuses on generating attractive yields for unitholders by strategically managing assets, minimizing costs, and maintaining a conservative capital structure with minimal debt. Growth is pursued through accretive acquisitions, often executed via non-taxable contribution and exchange agreements using equity issuance. The partnership agreement mandates quarterly distributions of available cash to unitholders. The company faces regulatory oversight from multiple federal and state agencies governing drilling, environmental compliance, and taxation. Its customer base includes major oil companies such as Exxon Mobil and Chevron, which accounted for about 25% of operating revenues in 2025.

Astrotech Corporation is a technology company specializing in mass spectrometry and gas chromatography analytical instruments designed for real-time chemical detection in high-demand environments such as security checkpoints, cargo hubs, and agricultural processing. The company commercializes its proprietary Astrotech Mass Spectrometer Technology (AMS Technology) through wholly owned subsidiaries focused on specific applications. 1st Detect Corporation develops security products including the TRACER 1000™ explosives and narcotics trace detectors, which have received certifications and approvals from European and U.S. authorities. AgLAB Inc. targets the hemp and cannabis markets with mass spectrometry solutions to optimize oil distillation yields. Astrotech's business model involves licensing its core technology to subsidiaries that develop and market application-specific products. The company has secured government contracts and sales orders, and continues product development and certification efforts. Financially, Astrotech has incurred significant losses and maintains a need for additional capital to fund operations and growth.

KKR & Co. Inc. is a global alternative asset management firm founded in 1976, known for pioneering leveraged buyouts. The company has expanded its investment strategies beyond traditional private equity to include leveraged credit, alternative credit, infrastructure, real estate, energy, growth equity, and core private equity. It operates through three main segments: Asset Management, Insurance (via Global Atlantic), and Strategic Holdings. Asset Management encompasses five business lines and manages a diversified portfolio of assets globally. The insurance segment offers retirement and life insurance products and reinsurance solutions, serving millions of policyholders. Strategic Holdings manages long-term ownership stakes in operating companies, primarily in private equity. KKR reported $796 billion in assets under management as of June 30, 2026, with a global footprint of 36 offices. The firm’s revenue and net income for Q2 2026 were $5.73 billion and $700 million, respectively. KKR’s business is influenced by global economic conditions, regulatory environments, and market dynamics.